22nd Nov 2013 16:12
LONDON (Alliance News) - Oxford Immunotec Global PLC, a portfolio holding of technology investment group Imperial Innovations Group PLC, started trading on NASDAQ Friday.
Oxford Immunotec is a medical diagnostics company developing novel new tests for various diseases based on world-leading research at the University of Oxford.
The shares are trading in New York under the symbol OXFD.
Imperial Innovations, which focuses on technologies developed at Imperial College London, has not sold any of its Oxford Immunotec shares during the listing process and now owns a stake of 5.1%.
Imperial Innovations has invested USD9.5 million in Oxford Immunotec and last year led a USD28 million funding round for the company. At the issue price of USD12.00 per share, Imperial Innovations' holding is worth USD10 million.
Imperial Innovations was trading at 450.00 pence Friday, up 20.00 pence or 4.7%.
By Anthony Tshibangu; [email protected];
Copyright © 2013 Alliance News Limited. All Rights Reserved.
Related Shares:
Imperial Innovations Group